Fluorescence imaging with indocyanine green during breast cancer surgery and postmastectomy breast reconstruction: A double systematic review and cost analysis
Although further studies remain necessary, using indocyanine green fluorescence imaging during breast cancer surgery and breast reconstruction appears to appreciably lower costs, both by eliminating the need for technetium Tc 99m and by reducing perfusion-related complications.
Authors
- Peter C. Neligan (ORCID: https://orcid.org/0000-0003-4439-2205)
- Kevin P. White
- Vassilis Pitsinis
- Martin Newman
- Annemiek Doeksen
- Patrick E. Goldhawk-White
- Ciara McGoldrick
- Rutger M. Schols
Institutions
- University of Ulster (GB)
- University of Washington (US)
- London Health Sciences Centre (CA)
- Ninewells Hospital (GB)
- Belfast City Hospital (GB)
- St. Antonius Ziekenhuis (NL)
- Cleveland Clinic Florida (US)
- Zuyderland Medisch Centrum (NL)
Publication Details
- Journal
- Surgery
- Published
- 2026-01-21
- DOI
- https://doi.org/10.1016/j.surg.2025.110052
- Citations
- 1
- Primary Topic
- Breast Implant and Reconstruction
- Type
- article
- Field-Weighted Citation Impact
- 39.15